| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 42, 498-506, Copyright © 1996 by American Association for Clinical Chemistry
I Jialal and S Devaraj
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, 75235-9052, USA.
Cardiovascular disease is the leading cause of mortality in westernized populations. An increased concentration of plasma low-density lipoprotein (LDL) cholesterol constitutes a major risk factor for atherosclerosis. Several lines of evidence support a role for oxidatively modified LDL in atherosclerosis and for its in vivo existence. Antioxidants have been shown to decrease atherosclerotic lesion formation in animal models and decrease LDL oxidation; the evaluation of LDL oxidation in vivo is therefore very important. However, there is a paucity of methods for direct measurement of LDL oxidation. Of the direct methods currently available, the preferred ones seem to be the measurement of F2-isoprostanes, autoantibodies to epitopes on oxidized LDL, and the assessment of antioxidant status. Of the indirect measures, the most uniformly accepted procedure is examining the oxidative susceptibility of isolated LDL by monitoring conjugated diene formation.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  G. D. Wool, C. A. Reardon, and G. S. Getz Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties J. Lipid Res., June 1, 2008; 49(6): 1268 - 1283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Dursun, E. Demirtas, A. Bayrak, and H. Yarali Decreased serum paraoxonase 1 (PON1) activity: an additional risk factor for atherosclerotic heart disease in patients with PCOS? Hum. Reprod., January 1, 2006; 21(1): 104 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mohn, M. Catino, R. Capanna, C. Giannini, M. Marcovecchio, and F. Chiarelli Increased Oxidative Stress in Prepubertal Severely Obese Children: Effect of a Dietary Restriction-Weight Loss Program J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2653 - 2658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. V. Khan, S. Sola, W. B. Lauten, R. Natarajan, W. C. Hooper, R. G. Menon, S. Lerakis, and T. Helmy Quinapril, an ACE Inhibitor, Reduces Markers of Oxidative Stress in the Metabolic Syndrome Diabetes Care, July 1, 2004; 27(7): 1712 - 1715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-P. Wang, X.-J. Feng, B.-D. Gou, T.-L. Zhang, S.-J. Xu, and K. Wang Effects of LDL, Cholesterol, and Their Oxidized Forms on the Precipitation Kinetics of Calcium Phosphates Clin. Chem., December 1, 2003; 49(12): 2027 - 2036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhou, A. J. Ryan, J. Medh, and R. K. Mallampalli Oxidized Lipoproteins Inhibit Surfactant Phosphatidylcholine Synthesis via Calpain-mediated Cleavage of CTP:Phosphocholine Cytidylyltransferase J. Biol. Chem., September 26, 2003; 278(39): 37032 - 37040. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Bureau, F. Laporte, M. Favier, H. Faure, M. Fields, A. E. Favier, and A.-M. Roussel No Antioxidant Effect of Combined HRT on LDL Oxidizability and Oxidative Stress Biomarkers in Treated Post-Menopausal Women J. Am. Coll. Nutr., August 1, 2002; 21(4): 333 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Kasvosve, J. R Delanghe, Z. A. Gomo, I. T Gangaidzo, H. Khumalo, M. R Langlois, V. M Moyo, T. Saungweme, E. Mvundura, J. R Boelaert, et al. Effect of transferrin polymorphism on the metabolism of vitamin C in Zimbabwean adults Am. J. Clinical Nutrition, February 1, 2002; 75(2): 321 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Devaraj, S. V. Hirany, R. F. Burk, and I. Jialal Divergence between LDL Oxidative Susceptibility and Urinary F2-Isoprostanes as Measures of Oxidative Stress in Type 2 Diabetes Clin. Chem., November 1, 2001; 47(11): 1974 - 1979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Poirier, O. Michel, R. Bazin, J. Bariety, J. Chevalier, I. Myara, and A.-T. Gaston Conjugated dienes: a critical trait of lipoprotein oxidizability in renal fibrosis Nephrol. Dial. Transplant., August 1, 2001; 16(8): 1598 - 1606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bub, B. Watzl, L. Abrahamse, H. Delincée, S. Adam, J. Wever, H. Müller, and G. Rechkemmer Moderate Intervention with Carotenoid-Rich Vegetable Products Reduces Lipid Peroxidation in Men J. Nutr., September 1, 2000; 130(9): 2200 - 2206. [Abstract] [Full Text]
|
|
|
|
|
|
S.-E. Bursell and G. L. King The Potential Use of Glutathionyl Hemoglobin as a Clinical Marker of Oxidative Stress Clin. Chem., February 1, 2000; 46(2): 145 - 146. [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Morrison, D. W. Jacobsen, D. L. Sprecher, K. Robinson, P. Khoury, and S. R. Daniels Serum Glutathione in Adolescent Males Predicts Parental Coronary Heart Disease Circulation, November 30, 1999; 100(22): 2244 - 2247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. T. Chan, W. P. Fong, Y. L. Cheung, Y. Huang, W. K. K. Ho, and Z.-Y. Chen Jasmine Green Tea Epicatechins Are Hypolipidemic in Hamsters (Mesocricetus auratus) Fed a High Fat Diet J. Nutr., June 1, 1999; 129(6): 1094 - 1101. [Abstract] [Full Text]
|
|
|
|
|
|
A. M. Gotto and G. R. Cooper Citation Classics in Lipid Measurement and Applications Clin. Chem., November 1, 1998; 44(11): 2234 - 2237. [Full Text] [PDF]
|
|
|
|
|
|
P. B. Duell, D. L. Wheaton, A. Shultz, and H. Nguyen Inhibition of LDL oxidation by melatonin requires supraphysiologic concentrations Clin. Chem., September 1, 1998; 44(9): 1931 - 1936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Jialal Evolving lipoprotein risk factors: lipoprotein(a) and oxidized low-density lipoprotein Clin. Chem., August 1, 1998; 44(8): 1827 - 1832. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
